What is happening. Intravenous vancomycin is nephrotoxic, particularly at high troughs or with prolonged courses, and renal impairment alters the clearance and balance of magnesium. Significant supplemental magnesium in a patient with vancomycin-associated acute kidney injury can accumulate and cause hypermagnesemia. There is no direct chemical interaction, but renal monitoring is warranted.
Mechanism. Vancomycin-induced nephrotoxicity reduces glomerular filtration, impairing renal excretion of magnesium; exogenous magnesium can then accumulate, risking hypermagnesemia. The interaction is mediated by drug-induced renal impairment rather than direct binding.
Recommendation. Patients on IV vancomycin, especially prolonged or high-dose courses, should have renal function and serum magnesium monitored. Avoid high-dose magnesium supplementation in the setting of reduced kidney function unless directed by a clinician. Oral vancomycin (minimal systemic absorption) does not meaningfully interact with magnesium.